Vertex Pharmaceuticals Incorporated (VRTXD)
Market Closed
7 Aug, 20:00
BCBA BCBA Primary BCBA $
5. 10
+0.15
+3.1345%
$
- Market Cap
30.83 P/E Ratio
- Div Yield
70 Volume
14.94 Eps
$ 4.95
Previous Close Want to track VRTXD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vertex Pharmaceuticals Incorporated (VRTXD) Statistics
Valuation metrics
Market Cap -
Enterprise value -4.12B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 0.24
Enterprise Value/Revenue -0.34
Enterprise Value/EBITDA -0.83
Overview
Shares outstanding -
Float 253.02M
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 223
Average volume (90 days) 130
Price summary
52-Week low 3.63
52-Week high 5.64
Beta 0.3
50-Day moving average 4.7
200-Day moving average 4.45
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.36%
Operating margin 0.38%
Operational effectiveness
Return on assets 0.12%
Return on equity 0.24%
Income Statement
Revenue (ttm) 12.22B
Revenue per share (ttm) 11.98
Quarterly revenue growth (yoy) 0.08%
Gross profit (ttm) 6.65B
EBITDA 4.98B
Net income to common (ttm) 4.34B
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) 0.6%
Balance Sheet
Total cash (mrq) 7.25B
Total cash per share (mrq) 28.55
Total debt (mrq) 1.99B
Total Debt/Equity (mrq) 10.26
Current ratio (mrq) 3.02%
Book value per share (mrq) 19.04
Cash Flow
Cash flow statement 4.24B
Levered free cash flow (LFCF) 2.78B
